AzTrials
AzTrials

Muscle Strength RecoveryNCT03063346

The Effect of a Protein Hydrolysate on Muscle Strength Recovery

A study testing Protein hydrolysate high dose and Protein hydrolysate low dose in people with Muscle Strength Recovery, run by BioActor.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Overtraining is a real problem for (semi-)professional athletes. Overtraining is often caused by the bodies' lack of ability to recover between training. In addition, during high intensity training reactive oxygen species are formed up to 20 fold compared to resting values. Read more about this study

Who is it for?
Ages 18 to 35 yearsHealthy volunteers can take part
Conditions the study is for
Muscle Strength Recovery
What is being tested?
Protein hydrolysate high dose and Protein hydrolysate low dose
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
48 participants
Where
No sites listed yet
Study dates
6 Jun 2016to 20 Feb 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Healthy individuals (based on their medical history provided during a general health questionnaire)
  • Participants are amateur or (semi-) professional athletes in resistance or interval sports (engage in >6 hours of intense physical activity per week).
  • Age 18 - 35
  • Experience in resistance training

Who cannot join

  • Use of creatine supplements and/or anabolic steroids.
  • Allergy to test product/protein
  • Allergy to specific protein hydrolysate
  • BMI lower than 18 or higher than 30.
  • Lack of technique in correctly performing a barbell squat (judged by sports physiologist).
  • Recent muscle injury in legs or back less than one month before the start of the study.
Show all 10Show fewer
  • Cardiovascular complications
  • Use of medication
  • Administration of investigational drugs or participation in any scientific intervention study which may interfere with this study (to be decided by the principle investigator), in the 180 days prior to the study.
  • Abuse of products; alcohol (> 20 alcoholic units per week) and drugs

About this study

Official title: The Effect of a Protein Hydrolysate on Muscle Strength Recovery in Athletes

Overtraining is a real problem for (semi-)professional athletes. Overtraining is often caused by the bodies' lack of ability to recover between training. In addition, during high intensity training reactive oxygen species are formed up to 20 fold compared to resting values. This causes increased muscle tissue damage after intense exercise, which slows down recovery. Improving recovery may increase an athlete's ability to reach higher training volumes resulting in establishing a higher performance plateau.

It is known that hydrolyzed proteins have a positive effect on muscle protein synthesis due to its faster absorption rate. Therefore, it is hypothesized that a known protein hydrolysate may have positive effects on strength recovery.

Being tested
Protein hydrolysate high dose, Protein hydrolysate low dose, Placebo

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Protein hydrolysate high doseDietary supplement

  • Protein hydrolysate low doseDietary supplement

  • PlaceboDietary supplement

Study groups in NCT03063346
Study groupRoleWhat they receive
Protein hydrolysate high doseExperimentalNot described
Receives: Dietary Supplement: Protein hydrolysate high dose
Protein hydrolysate low doseExperimentalNot described
Receives: Dietary Supplement: Protein hydrolysate low dose
PlaceboPlacebo comparatorNot described
Receives: Dietary Supplement: Placebo

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Muscle strength recovery

    difference in peak force between the exhaustion challenge and the recovery challenge, measured with a linear encoder during a squat exercise

    Measured: 4 weeks

Secondary outcomes (4)
  1. Blood lactate buildup

    in mmol/L, measured trough a finger prick after exhaustion and recovery challenge

    Measured: 4 weeks

  2. Body composition

    fat percentage, based on 4-point skin fold measurement

    Measured: 4 weeks

  3. Exercise volume

    amount of repetitions x time taken x power, measured with a linear encoder during squat exercise

    Measured: 4 weeks

  4. Peak force output

    measured with a linear encoder during the squat exercise

    Measured: 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Feb 2017
  2. Study start6 Jun 2016
  3. Primary completion9 Feb 2017
  4. Study completion20 Feb 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
48 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03063346
Sponsor's protocol ID
MU-001
Status last verified
Mar 2017
First submitted
2 Feb 2017
Last updated
3 Mar 2017
Results posted
No
Data monitoring committee
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Protein hydrolysate high dose and Protein hydrolysate low dose in people with Muscle Strength Recovery, run by BioActor.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Mar 2017. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Muscle strength recovery (time frame: 4 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Mar 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in